Maven Income
and Growth VCT 3 PLC
Interim Results
for the Six Months Ended 31 May 2024
Highlights
• NAV total return at 31 May
2024 of 151.16p per share
• NAV at 31 May 2024 of
51.44p per share
• Interim dividend of 1.00p
per share
• Offer for Subscription
closed, raising £5.2 million
• Four new private companies
added to the portfolio
• Exit achieved from
GradTouch, generating a total return of 1.5x cost
• Post period end, final exit
achieved from Quorum Cyber generating a total return of 8.2x
cost
Interim
Review
Overview
In the six months to 31 May 2024, your Company has
made further positive progress and it is pleasing to report a
modest increase in NAV total return. Since the year end, your
Company has closed its most recent Offer for Subscription,
completed four new private company investments and achieved three
profitable private company realisations, including the final exit
from Quorum Cyber, which generated a total return of 8.2x cost over
a holding period of less than four years. In general, the portfolio
of investee companies continues to deliver a resilient performance
and remains well placed to achieve further growth. In recognition
of the exit activity and the commitment to make regular tax free
distributions, an interim dividend of 1.00p per share has been
declared for payment in September 2024.
Following a prolonged period of macroeconomic
uncertainty, it is encouraging to note that market conditions are
improving. With inflation significantly reduced, energy prices in
decline and interest rates predicted to fall later in the year, the
outlook is more stable than it has been for several years. Whilst
it may take time for all of these improvements to filter through
the economy, the Manager is cautiously optimistic in the outlook
for the remainder of the financial year and believes that economic
growth will continue to strengthen in 2025.
Your Company continues to make further progress in
line with its long term growth strategy, which is focused on
constructing a large and diverse portfolio of innovative companies
that will scale and ultimately become attractive to a wide range of
acquirers. During the reporting period, there was a good level of
investment with the addition of four new private companies to the
portfolio, alongside the provision of follow-on funding to support
the further development of 15 existing portfolio holdings,
resulting in the deployment of £3 million. The investment strategy
continues to focus on identifying entrepreneurial companies that
operate in disruptive or high growth markets, where there is an
opportunity to achieve scale over the medium term. Maven retains a
strong preference for investing in companies that operate in
dynamic sectors such as cyber security, software, niche
manufacturing, data analytics, healthtech and training, where
growth is less sensitive to consumer or discretionary spending and
the revenue model tends to be recurring in nature, which provides
good visibility on the growth trajectory of each portfolio company.
To ensure the business plan can be delivered, Maven also spends
time assessing the calibre of management and their track record,
recognising that ambitious and cohesive teams are crucial to the
success of early stage businesses.
In April 2024, your Company closed its most recent
top-up Offer having raised a total of £5.2 million for the 2023/24
and 2024/25 tax years. These funds will enable your Company to
progress its investment strategy which, over the past four years,
has provided development capital to more than 40 private companies,
many of which are delivering strong growth and achieving a leading
position in their respective markets. As the portfolio develops, it
is becoming evident that there are a number of high performing
companies, which have the capability of achieving superior returns
at exit.
Over recent months, there has been an increase in the
level of acquisition interest across the portfolio, with approaches
to acquire or invest in several investee companies, particularly
from US investors, who are interested in the UK technology sector.
This is demonstrated by the recent successful exit from cyber
security specialist Quorum
Cyber, which completed in early June. Your Company first
invested in Quorum Cyber in 2020, backing an experienced team that
had quickly established a leading position in a high growth market.
Following a period of rapid expansion, the investment was partially
realised through a sale to UK private equity house, Livingbridge,
in January 2022, generating an initial return of 6.5x cost over an
18 month holding period. The transaction provided Quorum Cyber with
additional capital to support the next phase of its strategic
development and, in recognition of its continuing potential, the
Maven VCTs retained a minority equity interest in the business in
order to participate in future growth. It is pleasing to report
that in June this year, a final exit from this investment was
achieved through a sale of the business to US private equity firm,
Charlesbank Capital Partners, taking the total proceeds to 8.2x
cost.
Whilst achieving profitable exits, in pursuit of
Shareholder returns, remains a key priority, this has to be
balanced against selling a business too early before its value has
been optimised. In cases like Quorum Cyber, where a business is
performing strongly and has the potential to become a large and
valuable asset, the Manager will seek, where possible, to retain an
economic interest when structuring an exit. This approach will
allow your Company to generate an initial cash return from a
secondary transaction or partial sale, to help support the dividend
programme, whilst retaining an ongoing equity interest in the
business, which offers the potential for a further return in the
future.
Dividend
Policy
The Board and the Manager recognise the importance of
tax free distributions to Shareholders and will seek, as a guide,
to pay an annual dividend that represents 5% of the NAV per share
at the immediately preceding year end.
Decisions on distributions take into consideration a
number of factors, including the realisation of capital gains, the
adequacy of distributable reserves, the availability of surplus
revenue and the VCT qualifying level, all of which are kept under
close and regular review. As the portfolio continues to expand and
a greater proportion of holdings are invested in younger companies
with high growth potential, the timing of distributions will be
more closely linked to realisation activity, whilst also reflecting
the Company's requirement to maintain its VCT qualifying level.
Interim
Dividend
In respect of the year ending 30 November 2024, an
interim dividend of 1.00p per share will be paid on 6 September
2024 to Shareholders who are on the register at 9 August 2024.
Since the Company's launch, and after receipt of this interim
dividend, a total of 100.72p per share will have been paid in tax
free Shareholder distributions. It should be noted that the payment
of a dividend reduces the NAV of the Company by the total amount of
the distribution.
Dividend Investment
Scheme (DIS)
Your Company operates a DIS, through which
Shareholders can, at any time, elect to have their dividend
payments utilised to subscribe for new Ordinary Shares issued by
the Company under the standing authority requested from
Shareholders at Annual General Meetings. Shares issued under the
DIS should qualify for VCT tax relief applicable for the tax year
in which they are allotted, subject to an individual Shareholder's
particular circumstances.
Shareholders can elect to participate in the DIS in
respect of future dividends by completing a DIS mandate form and
returning it to the Registrar (The City Partnership). In order for
the DIS to apply to the 2024 interim dividend, the mandate form
must be received before 23 August 2024, this being the relevant
dividend election date. The mandate form, terms & conditions
and full details of the scheme (including tax considerations) are
available from the Company's webpages at: mavencp.com/migvct3. Election to
participate in the DIS can also be made through the Registrar's
online investor hub at: maven-cp.cityhub.uk.com/login.
If a Shareholder is in any doubt about the merits of
participating in the DIS, or their own tax status, they should seek
advice from a suitably qualified adviser.
Fund
raising
The most recent Offer for Subscription closed to new
applications on 26 April 2024, with your Company raising a total of
£5.2 million for the 2023/24 and 2024/25 tax years. All new shares
in relation to this Offer have now been allotted, with four
allotments for the 2023/24 tax year and one allotment for the
2024/25 tax year.
This additional liquidity will facilitate the further
expansion and development of the portfolio in line with the
investment strategy. The funds raised will also allow your Company
to maintain its share buy-back policy, whilst also spreading costs
over a wider asset base, with the objective of maintaining a
competitive ongoing charges ratio for the benefit of all
Shareholders.
As announced on 18 June 2024, the Directors have
elected to launch a new Offer for Subscription, which will run
alongside Offers by the other Maven managed VCTs. Full details will
be included in the Prospectus, which is expected to be published in
Autumn 2024.
Portfolio
Developments
It is encouraging to report on the progress that has
been achieved across the private company portfolio, where most
companies have continued to meet operational and financial targets
as part of their business plans. Notably, many of the earlier stage
growth companies are now achieving scale and establishing strong
positions in their respective markets, and in recognition of the
progress achieved the valuations of certain holdings have been
uplifted.
Carbon reduction software specialist Manufacture 2030 has delivered strong
revenue growth over the past year with annual recurring revenue
(ARR) increasing by over 75%. The business provides a disruptive
software solution that helps multinationals achieve Scope 3 carbon
reduction targets by measuring, managing and reducing carbon
emissions across their supply chain. The business is gaining
commercial traction in a high growth market, where its proposition
is aligned with various carbon reduction initiatives including, the
United Nations Sustainable Development Goals. Manufacture 2030
partners with a wide range of blue chip clients including Asda,
Co-op, GSK, Toyota and Unilever, and has received a number of
awards as a technology pioneer within this evolving market. The
near term objective is to expand its presence in North America,
which is viewed as a key market.
Specialist electronics manufacturer CB Technology delivered a strong
performance in its latest financial year, which was supported by a
record forward orderbook that continues to provide good visibility
for the year ahead. CB Technology has also secured a number of new
clients, as part of a successful diversification strategy, with the
objective of reducing the reliance on oil & gas customers.
Cyber security specialist CYSIAM has made further commercial
progress with revenues increasing by more than 200% since your
Company first invested. The business is building a strong
reputation as a leading provider of Managed Detection and Response
(MDR) security services for protection against, detection of and
response to cyber attacks. CYSIAM is a recognised expert in its
field and, as an accredited member of the National Cyber Security
Centre's Cyber Incident Response scheme, it can provide direct
support to a range of organisations when they become victims of
cyber attacks. CYSIAM operates in a dynamic, high growth market and
the near term strategic objective remains to further pivot the
business towards a Software as a Service (SaaS) model, which will
result in an increased level of recurring revenue.
In 2021, your Company invested in Guru Systems, a supplier of hardware,
software and data analytics designed to improve the performance and
cost effectiveness of heat networks. Since investment, the business
has gained commercial traction in an emerging sector that has
positive ESG credentials. Heat networks are an important part of
the government's decarbonisation strategy and are increasingly
required to be included as part of the design of any new
residential or commercial property development. Given the strong
growth potential of this market, Guru is well placed to achieve
scale over the medium term.
During the period under review, digital archiving
specialist MirrorWeb has
continued to deliver impressive revenue growth and add new clients.
Following the relocation of the CEO to the US to lead the
international expansion strategy, the business has continued to
scale rapidly, particularly within the financial services sector,
where regulatory changes now require all digital communications to
be archived. MirrorWeb has also focused on developing a new
platform with enhancements and additional product functionality,
which provides good upselling potential within the existing client
base.
Automotive ecommerce software specialist Rockar, continues to grow market share
and is now a leading provider of a white label disruptive solution
for buying and selling new and used cars online. The business has
developed good relationships with various high profile automotive
manufacturers such as BMW, Jaguar Land Rover, Toyota Motor Group
and Volvo UK, with development work ongoing with several others.
Rockar's new operating platform, Evolution, is gaining traction amongst
clients, with a number already using or committed to migrating
across to the new operating system. The business continues to
deliver strong revenue growth and remains focused on building
relationships with global automotive manufacturers that will enable
the company to achieve further scale.
Digital payments software provider QikServe has continued to make
encouraging commercial progress and is capitalising on the shift
within the hospitality sector towards mobile ordering and
pay-at-table technology.
The business continues to expand its market presence in targeted
sectors, which include restaurants, international coffee chains and
transportation hubs. QikServe has a growing estate with more than
8,000 sites in over 40 countries and a healthy pipeline of near
term opportunities, particularly in the US.
Contract software specialist Summize continues to make positive
commercial progress, with ARR growing by almost 200% since the
investment first completed in October 2022. Summize has developed
an AI-powered digital contracting software solution that simplifies
and streamlines the process for writing and renewing contracts,
helping to drive operational efficiencies for customers. Since
inception in 2018, Summize has secured numerous industry awards for
its innovation and entrepreneurialism. Having established a strong
foothold in the UK, the next phase of growth for the business is to
expand into the US, where there is the potential to exploit a
significant market opportunity.
As may be expected with a large portfolio, there are a
small number of investee companies that have not achieved
commercial targets and are trading behind plan. Protective
provisions have, therefore, been taken against the cost of certain
holdings. The performance of fintech specialist Delio has been impacted by slower than
expected sales cycles and although corrective measures have been
taken, the business continues to trade behind plan. Challenging
market conditions have impacted the growth rate of creative
marketing agency TC
Communications. It is disappointing to report that the small
investment in marketing technology business Drovo has been written down in
full.
Treasury
Management
Your Company maintains a proactive approach to
treasury management, where the objective remains to optimise the
income generated from cash held prior to investment in VCT
qualifying companies, whilst meeting the requirements of the Nature
of Income condition. This is a mandatory part of the VCT
legislation, which stipulates that not less than 70% of a VCT's
income must be derived from shares or securities. During 2023, the
rise in interest rates required the Board and the Manager to revise
its approach and, following a whole of market review, the
composition of the treasury management portfolio was expanded to
include holdings in leading money market funds and open-ended
investment companies (OEIC), alongside carefully selected London
Stock Exchange listed investment trusts. This approach enables your
Company to maintain compliance with the Nature of Income condition,
whilst also generating a healthy new stream of income from the
portfolio of treasury management holdings and cash.
In line with the liquidity requirements of your
Company, there have been several new investments and realisations
within this portfolio, details of which can be found in the Interim
Report.
New
Investments
During the reporting period, four new private
companies were added to the portfolio:
•
Alderley Lighthouse Labs is
a provider of clinical diagnostic testing services, specialising in
the analysis of human samples such as blood, urine and cells, with
the objective of improving healthcare outcomes. The business was
initially established as a COVID-19 facility, as part of the
Government supported "Test and Trace" programme. As pandemic
related testing subsided, the business evolved into a
laboratory-based testing facility providing blood science and
molecular diagnostics to a wide range of clients. The healthcare
diagnostics and testing market continues to experience high growth,
and Alderley is well placed to leverage its existing position, with
scope to achieve considerable scale. The funding from the Maven
VCTs provides capital that will enable the business to invest in
product development, expand its current suite of services and grow
monthly revenues.
•
McKenzie Intelligence Services
(MIS) is an insurtech business that provides insurers with
geospatial data and analysis to accelerate responses to
catastrophic events, helping to drive disaster relief and economic
recovery. Its proprietary data-led intelligence platform,
Global Events Observer,
uses real time information, machine learning and expert analysis to
provide detailed and actionable intelligence to help decision
makers manage risk, escalate relief and promote economic recovery
in scenarios of extreme weather, natural disasters and geopolitical
conflict. Since 2017, MIS has been Lloyds of London's catastrophic
claims partner and has provided data and assistance following
several high profile incidents, including the 2023 wildfires in
Hawaii. The funding from the Maven VCTs is being used to further
develop the technology platform and to launch new products that
offer unique insight into future potential risks.
•
Metrion Biosciences is a
specialist contract research organisation that provides drug
discovery services to pharma and biotech customers. Its highly
specialised service is required in the development of drugs that
intentionally or unintentionally act on an important group of
protein structures within the body known as ion channels, which are one of the
fastest growing areas of innovation in drug discovery. Metrion is
aiming to become the outsourcing partner of choice for ion services
in the global pharma and biotech industry. The funding from the
Maven VCTs is being used to invest in new equipment and to create
additional laboratory space, which will enable Metrion to achieve
scale in this growing market.
•
Zing is a specialist
services provider operating in the cloud-communications sector. It
is a leading partner of global cloud communication platform
business Twilio, providing consultancy and managed services. Zing
was a spin out from CRM provider ProspectSoft, a previous Maven
portfolio company, which was successfully exited in 2022. The
funding from the Maven VCTs will enable the business to capitalise
on the growth opportunities in the Communications Platform as a
Service (CPaaS) market. Since becoming an independent business,
Zing has made encouraging progress and strengthened its
relationship with Twilio. The next stage of development is focused
on expanding into the US, developing a new AI proposition and
enhancing the management team through new strategic hires.
The following investments were completed during the
reporting period:
|
Investments
|
Date
|
Sector
|
£'000
|
|
New unlisted
|
|
|
|
|
Alderley Lighthouse Labs
Limited1
|
April & May 2024
|
Pharmaceuticals,
biotechnology & healthcare
|
249
|
|
McKenzie Intelligence
Services Limited
|
December 2023
|
Business services
|
159
|
|
Metrion Biosciences
Limited
|
December 2023
|
Pharmaceuticals,
biotechnology & healthcare
|
597
|
|
Zing TopCo Limited
(trading as
Zing)1
|
April & May 2024
|
Business services
|
185
|
|
Total new unlisted
|
|
|
1,190
|
|
Follow-on unlisted
|
|
|
|
|
Bud Systems Limited
|
May 2024
|
Learning & development/
recruitment technology
|
116
|
|
Delio Limited
|
February 2024
|
Software &
technology
|
125
|
|
Draper & Dash Limited
(trading as RwHealth)1
|
April & May 2024
|
Pharmaceuticals,
biotechnology & healthcare
|
51
|
|
Enpal Limited
(trading as Guru
Systems)
|
December 2023
|
Software &
technology
|
200
|
|
Hublsoft Group Limited
|
April 2024
|
Software &
technology
|
56
|
|
Liftango Group Limited
|
March 2024
|
Software &
technology
|
265
|
|
mypura.com Group Limited
(trading as Pura)
|
March 2024
|
Business services
|
193
|
|
Shortbite Limited
(trading as Fixtuur)
|
April 2024
|
Software &
technology
|
38
|
|
Snappy Shopper Limited
|
April 2024
|
Software &
technology
|
11
|
|
Turnkey Group (UK) Holdings
Limited2
|
December 2023, January,
February &
April 2024
|
Software &
technology
|
240
|
|
Whiterock Group Limited
|
December 2024
|
Software &
technology
|
149
|
XR Games Limited1
|
December 2023 &
February 2024
|
Software &
technology
|
148
|
|
Zinc Digital Business Solutions
Limited1
|
March & May 2024
|
Software &
technology
|
233
|
|
Total follow-on
unlisted
|
|
|
1,825
|
|
|
|
|
|
|
Total
unlisted
|
|
|
3,015
|
|
Follow-on AIM
quoted
|
|
|
|
|
GENinCode PLC
|
January 2024
|
Pharmaceuticals,
biotechnology & healthcare
|
160
|
|
RUA Life Sciences PLC
|
December 2023
|
Pharmaceuticals,
biotechnology & healthcare
|
33
|
|
Total follow-on AIM
quoted
|
|
|
193
|
|
Money market
funds3
|
|
|
|
|
Aviva Investors Sterling Liquidity Fund (Class 3)
|
March 2024
|
Money market fund
|
1,000
|
|
Fidelity Institutional Liquidity Sterling Fund (Class
F)
|
April 2024
|
Money market fund
|
500
|
|
HSBC Sterling Liquidity Fund (Class A)
|
March 2024
|
Money market fund
|
1,000
|
|
Total money market
funds
|
|
|
2,500
|
|
|
|
|
|
|
Total
investments
|
|
|
5,708
|
|
|
|
|
|
|
| |
1 Follow-on investment completed in two tranches.
2 Follow-on investment completed in four tranches.
3 Investments completed as part of the treasury management
strategy.
At the period end, the portfolio comprised of 114
unlisted and quoted investments, at a total cost of £51.3
million.
Realisations
In December 2023, the exit from Glacier Energy Services completed,
through a sale to a private equity buyer, which generated a total
return of 1.05x cost over the life of the investment. Glacier was
one of the more mature holdings in the portfolio and the exit helps
further reduce your Company's exposure to the energy services
sector.
In May 2024, the exit from graduate recruitment
specialist GradTouch
completed. Your Company first invested in GradTouch in November
2019, backing a team with a strategic plan to build a market
leading position in the graduate recruitment market. Throughout the
period of ownership, the company achieved steady organic growth
alongside a series of self funded, complementary acquisitions which
helped transform the business. During the period under review, an
offer to acquire the business was received from UK private equity
house Pelican Capital, with the exit generating a total return of
1.5x cost, inclusive of a small deferred consideration.
The table below gives details of the realisations
completed during the reporting period:
Realisations
|
Year first
invested
|
Complete/
partial exit
|
Cost of shares
disposed
of
£'000
|
Value at 30
November
2023
£'000
|
Sales proceeds
£'000
|
Realised
gain/(loss)
£'000
|
Gain/(loss) over 30
November 2023 value
£'000
|
Unlisted
|
|
|
|
|
|
|
|
Glacier Energy Services
Holdings Limited
|
2011
|
Complete
|
686
|
544
|
519
|
(167)
|
(25)
|
GradTouch Limited
|
2019
|
Complete
|
400
|
585
|
605
|
205
|
20
|
Others
|
|
|
-
|
-
|
3
|
3
|
3
|
Total unlisted
|
|
|
1,086
|
1,129
|
1,127
|
41
|
(2)
|
AIM quoted
|
|
|
|
|
|
|
|
Oncimmune Holdings PLC
|
2021
|
Complete
|
100
|
14
|
13
|
(87)
|
(1)
|
RUA Life Sciences PLC
|
2020
|
Complete
|
133
|
76
|
42
|
(91)
|
(34)
|
Total AIM quoted
|
|
|
233
|
90
|
55
|
(178)
|
(35)
|
Money market funds1
|
|
|
|
|
|
|
|
Aviva Investors Sterling
Government Liquidity Fund
|
2023
|
Complete
|
1,000
|
1,000
|
1,000
|
-
|
-
|
BlackRock Institutional
Sterling Liquidity Fund (Core)
|
2023
|
Complete
|
1,000
|
1,000
|
1,000
|
-
|
-
|
Fidelity Institutional
Liquidity Sterling Fund (Class F)
|
2023
|
Partial
|
1,000
|
1,000
|
1,000
|
-
|
-
|
Goldman Sachs Sterling
Liquid Reserves (Institutional)
|
2023
|
Complete
|
1,000
|
1,000
|
1,000
|
-
|
-
|
HSBC Sterling Liquidity Fund
(Class A)
|
2023
|
Partial
|
1,000
|
1,000
|
1,000
|
-
|
-
|
Total money market funds
|
|
|
5,000
|
5,000
|
5,000
|
-
|
-
|
|
|
|
|
|
|
|
|
Total sales
|
|
|
6,319
|
6,219
|
6,182
|
(137)
|
(37)
|
1 Realisations were completed as part of the treasury management
strategy.
During the year, one private company was struck
off the Register of Companies, resulting in a total realised loss
of £249,000 (cost £249,000). This had no effect on the NAV of the
Company as a full provision had been taken against the value of the
holding in a previous period.
Principal and
Emerging Risks and Uncertainties
The principal and emerging risks and uncertainties
facing the Company were set out in full in the Strategic Report
contained within the 2023 Annual Report, and are the risks
associated with investment in small and medium sized unlisted and
AIM quoted companies which, by their nature, carry a higher level
of risk and are subject to lower liquidity than investments in
larger quoted companies. The valuation of investee companies may be
affected by economic conditions, the credit environment and other
risks including legislation, regulation, adherence to VCT
qualifying rules and the effectiveness of the internal controls
operated by the Company and the Manager. These risks and procedures
are reviewed regularly by the Audit & Risk Committee and
reported to your Board. The Board has confirmed that all tests,
including the criteria for VCT qualifying status, continue to be
monitored and met.
Global conflict and political instability was added to
the Risk Register as an emerging risk during a previous period, as
the Directors were not only aware of the heightened cyber security
risk but were mindful of the impact that any change in the
underlying economic conditions could have on the valuation of
investment companies. These included fluctuating interest rates,
increased fuel and energy costs, and the availability of bank
finance, all of which could be impacted during times of
geopolitical uncertainty and volatile markets. The Board and the
Manager continue to monitor the impact of geopolitical, and wider
market conditions, on portfolio companies.
Share
Buy-backs
In order to maintain an orderly market in the
Company's shares, the Directors have delegated authority to the
Manager to enable the Company to buy back shares in the secondary
market for cancellation or to be held in treasury, subject always
to such transactions being in the best interests of
Shareholders.
It is intended that the Company will seek to buy back
shares with a view to maintaining a share price that is at a
discount of approximately 5% to the latest published NAV per share,
subject to market conditions, available liquidity and the
maintenance of the Company's VCT qualifying status. During the
period under review, 1,250,126 shares were bought back at a total
cost of £617,000.
Shareholders should note that neither the Company nor
the Manager can execute a transaction in the Company's shares and
an instruction to buy or sell shares on the secondary market must
be directed through a stockbroker. If a Shareholder wishes to
discuss a transaction, they or their broker can contact the
Company's stockbroker, Shore Capital Stockbrokers on 020 7647 8132.
Such transactions are, however, prohibited whilst the Company is in
a closed period, which is the time from the end of a reporting
period until the announcement of the relevant results, or the
release of an unaudited NAV. Additionally, a closed period may be
introduced if the Directors and Manager are in possession of price
sensitive information.
VCT Regulatory
Update
During the period under review, there were no further
amendments to the rules governing VCTs, and your Company remains
fully compliant with the complex conditions and requirements as set
out by HMRC.
Although the precise details of the new government's
economic and fiscal policy are currently unknown, the Manager has,
through the VCT Association (VCTA), been actively involved in
positive cross party dialogue to promote and reinforce the
important role that VCTs play in supporting some of Britain's
brightest and most entrepreneurial smaller companies, whilst also
assisting in job creation across the regions. The announcement in
the 2023 Autumn Statement that the "sunset clause" for VCT and EIS
schemes would be extended until 2035 helps to ensure that VCTs
remain an important component of the UK's funding
infrastructure.
Valuation
Methodology
Consistent with industry best practice, the Board and
the Manager continue to apply the International Private Equity and
Venture Capital Valuation (IPEV) Guidelines as the central
methodology for all private company valuations. The IPEV Guidelines
are the prevailing framework for fair value assessment in the
private equity and venture capital industry. The Directors and the
Manager continue to follow industry guidelines and adhere to the
IPEV Guidelines in all private company valuations. In accordance
with normal market practice, investments quoted on AIM, or another
recognised stock exchange, are valued at their closing bid price at
the period end.
Environmental, Social
and Governance (ESG)
Whilst the Manager continues to enhance its ESG
framework, it should be noted that your Company's investment policy
does not incorporate specific ESG aims, and portfolio companies are
not required to meet any specific targets. However, as a growth
investor, Maven is well positioned to help each company establish
robust ESG practices at an early stage of its corporate
development, ensuring that they are ingrained in the culture as the
business grows. The Manager believes that strong core ESG
credentials help to support responsible growth and encourage
positive social and environmental behaviours.
Your Company has multiple investments in companies
with strong ESG credentials that are achieving growth in expanding
markets. The Manager is committed to maintaining a responsible
approach to new and existing investments and has developed a
framework for promoting ESG credentials by actively engaging with
portfolio companies, taking into consideration material issues at
the point of investment and monitoring progress annually. All
potential investment opportunities are required to complete an ESG
assessment, which covers 10 key areas and provides a comprehensive
pre-investment evaluation of the business with a focus on
governance, board composition and culture, alongside environmental
and social considerations.
The Manager continues to be an active signatory to the
UN Principles for Responsible Investment (UNPRI) and Investing in
Women Code. Alongside these external initiatives, Maven has
developed internal diversity initiatives, including launching a
Female Founder Funding programme, which aims to offer mentorship
and collaboration opportunities to female entrepreneurs across the
UK.
Outlook
With a small number of exceptions, the underlying
portfolio of investee companies has delivered a resilient
performance over the past few years and it is well positioned to
achieve further growth. Whilst 2023 was a slow year for exits
across the private equity industry, there is clear evidence that
M&A activity is improving. In addition to the three profitable
private company exits completed in the year to date, the companies
within the unlisted portfolio continue to attract regular
acquisition interest from a wide range of credible UK and
international acquirers. The completion of further profitable exits
remains a key objective and will continue to be a focus of
attention in the second half of the year, to help support your
Company's dividend programme.
Keith
Pickering
Chair
18 July
2024
Summary Of Investment
Changes
Six Months Ended 31
May 2024
|
Valuation
30 November 2023
|
Net investment/ (disinvestment)
£'000
|
Appreciation/ (depreciation)
£'000
|
Valuation
31 May 2024
|
|
£'000
|
%
|
£'000
|
%
|
Unlisted
investments
|
|
|
|
|
|
|
Equities
|
31,703
|
53.4
|
1,993
|
1,151
|
34,847
|
55.3
|
Loan stock
|
7,930
|
13.4
|
(105)
|
39
|
7,864
|
12.5
|
|
39,633
|
66.8
|
1,888
|
1,190
|
42,711
|
67.8
|
AIM1
|
|
|
|
|
|
|
Equities
|
1,284
|
2.2
|
138
|
187
|
1,609
|
2.6
|
Other
investments2
|
|
|
|
|
|
|
OEICs
|
2,027
|
3.4
|
-
|
1
|
2,028
|
3.2
|
MMFs
|
8,000
|
13.5
|
(2,500)
|
-
|
5,500
|
8.7
|
Investment trusts
|
4,881
|
8.2
|
-
|
329
|
5,210
|
8.3
|
Total
investments
|
55,825
|
94.1
|
(474)
|
1,707
|
57,058
|
90.6
|
Other net assets
|
3,512
|
5.9
|
2,410
|
-
|
5,922
|
9.4
|
Net assets
|
59,337
|
100.0
|
1,936
|
1,707
|
62,980
|
100.0
|
1 Shares traded on the Alternative
Investment Market (AIM) and the Main Market of the London Stock
Exchange.
2 These holdings represent the
treasury management portfolio, which has been constructed from a
range of carefully selected, permitted non-qualifying holdings in
investment trusts, open-ended investment companies (OEICs) and
money market funds (MMFs).
Investment Portfolio
Summary
As At 31 May
2024
Investment
|
Valuation
£'000
|
Cost
£'000
|
% of
total
assets
|
% of
equity
held
|
% of equity held by other
clients1
|
Unlisted
|
|
|
|
|
|
Horizon Ceremonies Limited
(trading as Horizon Cremation)
|
2,798
|
1,288
|
4.3
|
8.7
|
44.0
|
Bright Network (UK)
Limited
|
2,338
|
1,139
|
3.7
|
7.1
|
32.0
|
MirrorWeb Limited
|
1,778
|
690
|
2.8
|
3.8
|
46.1
|
Rockar 2016 Limited (trading
as Rockar)
|
1,630
|
971
|
2.6
|
4.3
|
15.1
|
Ensco 969 Limited (trading
as DPP)
|
1,211
|
957
|
1.9
|
4.8
|
29.7
|
NorthRow Limited
|
1,115
|
1,115
|
1.8
|
8.9
|
23.9
|
HCS Control Systems Group
Limited
|
1,099
|
746
|
1.7
|
6.1
|
30.4
|
CB Technology Group
Limited
|
1,045
|
558
|
1.7
|
10.6
|
64.4
|
Project Falcon Topco Limited
(trading as Quorum Cyber)2
|
1,005
|
335
|
1.6
|
0.8
|
2.1
|
Bud Systems Limited
|
953
|
762
|
1.5
|
4.1
|
13.5
|
CYSIAM Limited
|
944
|
448
|
1.5
|
5.8
|
22.0
|
Nano Interactive Group
Limited
|
929
|
625
|
1.5
|
3.7
|
11.2
|
BioAscent Discovery
Limited
|
898
|
199
|
1.4
|
5.0
|
35.0
|
Hublsoft Group Limited
|
882
|
705
|
1.4
|
5.5
|
18.2
|
Martel Instruments Holdings
Limited
|
879
|
671
|
1.4
|
12.4
|
31.8
|
DiffusionData Limited
|
873
|
625
|
1.4
|
3.1
|
14.9
|
Vodat Communications Group
(VCG) Holding Limited
|
852
|
567
|
1.4
|
5.0
|
26.9
|
Summize Limited
|
846
|
448
|
1.3
|
2.9
|
29.6
|
2degrees Limited (trading as
Manufacture 2030)
|
831
|
598
|
1.3
|
2.1
|
9.0
|
Filtered Technologies
Limited
|
816
|
750
|
1.3
|
7.6
|
17.8
|
QikServe Limited
|
801
|
658
|
1.3
|
3.0
|
12.8
|
Zinc Digital Business
Solutions Limited
|
799
|
647
|
1.3
|
10.9
|
32.7
|
WaterBear Education
Limited
|
767
|
370
|
1.2
|
7.7
|
31.1
|
Liftango Group Limited
|
763
|
763
|
1.2
|
5.0
|
35.7
|
Precursive Limited
|
750
|
750
|
1.2
|
5.5
|
29.0
|
Relative Insight Limited
|
700
|
700
|
1.1
|
2.7
|
28.6
|
Whiterock Group Limited
|
677
|
470
|
1.1
|
8.0
|
29.9
|
CODILINK UK Limited (trading
as Coniq)
|
675
|
450
|
1.1
|
1.3
|
3.6
|
XR Games Limited
|
637
|
298
|
1.0
|
1.6
|
21.5
|
mypura.com Group Limited
(trading as Pura)
|
608
|
409
|
1.0
|
1.6
|
21.2
|
Plyable Limited
|
597
|
597
|
0.9
|
6.8
|
19.8
|
Sensoteq Limited
|
597
|
597
|
0.9
|
5.6
|
18.0
|
Metrion Biosciences
Limited
|
597
|
597
|
0.9
|
4.3
|
13.9
|
Enpal
Limited (trading as Guru
Systems)
|
581
|
581
|
0.9
|
3.2
|
18.4
|
Boomerang Commerce Inc
(trading as CommerceIQ)3
|
580
|
773
|
0.9
|
0.1
|
0.3
|
Novatus Global Limited
|
562
|
562
|
0.9
|
3.5
|
15.2
|
The Algorithm People Limited
(trading as Optimize)
|
558
|
420
|
0.9
|
6.1
|
10.2
|
Cat Tech International
Limited
|
510
|
627
|
0.8
|
6.0
|
24.0
|
Laverock Therapeutics
Limited
|
498
|
498
|
0.8
|
2.3
|
7.0
|
Delio Limited
|
485
|
833
|
0.8
|
5.0
|
13.4
|
TC Communications Holdings
Limited
|
484
|
980
|
0.8
|
9.8
|
25.5
|
Draper & Dash Limited
(trading as RwHealth)
|
479
|
479
|
0.8
|
6.3
|
42.6
|
Horizon Technologies
Consultants Limited
|
466
|
448
|
0.7
|
3.1
|
14.1
|
ORCHA Health Limited
|
431
|
431
|
0.7
|
1.1
|
6.6
|
Flow UK Holdings Limited
|
420
|
597
|
0.7
|
7.0
|
28.0
|
Biorelate Limited
|
419
|
348
|
0.7
|
2.0
|
23.7
|
Turnkey Group (UK) Holdings
Limited
|
412
|
783
|
0.7
|
6.9
|
31.9
|
ebb3 Limited
|
370
|
326
|
0.6
|
9.3
|
69.6
|
HiveHR Limited
|
346
|
346
|
0.5
|
4.4
|
40.2
|
Growth Capital Ventures
Limited
|
331
|
319
|
0.5
|
5.8
|
41.6
|
Snappy Shopper Limited
|
309
|
309
|
0.5
|
0.4
|
1.3
|
AMufacture Limited
|
261
|
261
|
0.4
|
4.8
|
15.2
|
Alderley Lighthouse Labs
Limited
|
249
|
249
|
0.4
|
6.7
|
46.9
|
Shortbite Limited (trading
as Fixtuur)
|
248
|
560
|
0.4
|
7.0
|
63.9
|
iAM Compliant Limited
|
246
|
149
|
0.4
|
1.9
|
47.2
|
Zing TopCo Limited (trading
as Zing)
|
185
|
185
|
0.3
|
4.9
|
42.8
|
McKenzie Intelligence
Services Limited
|
159
|
159
|
0.3
|
1.6
|
4.8
|
Reed Thermoformed Packaging
Limited (trading as iPac Packaging Innovations)
|
140
|
100
|
0.2
|
0.5
|
11.8
|
RevLifter Limited
|
100
|
100
|
0.2
|
1.0
|
25.6
|
Rico Developments Limited
(trading as Adimo)
|
100
|
200
|
0.2
|
1.6
|
8.3
|
ISN Solutions Group
Limited
|
84
|
321
|
0.1
|
4.5
|
50.5
|
Other unlisted
investments
|
8
|
1,502
|
-
|
|
|
Total unlisted
|
42,711
|
34,949
|
67.8
|
|
|
AIM quoted4
|
|
|
|
|
|
GENinCode PLC
|
494
|
759
|
0.9
|
6.1
|
15.6
|
MaxCyte Inc
|
290
|
137
|
0.6
|
0.1
|
0.1
|
Diaceutics PLC
|
275
|
161
|
0.4
|
0.3
|
0.3
|
Kanabo Group
PLC5
|
191
|
1,611
|
0.3
|
2.0
|
8.0
|
AFC Energy PLC
|
82
|
57
|
0.1
|
-
|
-
|
C4X Discovery Holdings
PLC
|
82
|
119
|
0.1
|
0.3
|
0.6
|
Eden Research PLC
|
58
|
83
|
0.1
|
0.3
|
1.3
|
Feedback PLC
|
41
|
121
|
0.1
|
0.4
|
1.2
|
Vianet Group PLC
|
27
|
31
|
-
|
0.1
|
1.3
|
Spectral AI
|
21
|
99
|
-
|
-
|
-
|
Crossword Cybersecurity
PLC
|
16
|
122
|
-
|
0.4
|
1.7
|
ReNeuron Group PLC
|
13
|
278
|
-
|
0.7
|
1.4
|
Other quoted investments
|
19
|
889
|
-
|
|
|
Total AIM quoted
|
1,609
|
4,467
|
2.6
|
|
|
Private equity investment
trusts6
|
|
|
|
|
|
HgCapital Trust PLC
|
778
|
420
|
1.2
|
-
|
0.1
|
Patria Private Equity Trust
PLC (formerly abrdn Private Equity Opportunities Trust PLC)
|
542
|
373
|
0.9
|
0.1
|
0.2
|
ICG Enterprise Trust PLC
|
491
|
379
|
0.8
|
0.1
|
0.1
|
NB Private Equity Partners
Limited
|
360
|
371
|
0.6
|
0.1
|
0.2
|
CT Private Equity Trust
PLC
|
332
|
253
|
0.5
|
0.1
|
0.3
|
Princess Private Equity
Holding Limited
|
293
|
270
|
0.5
|
-
|
0.1
|
HarbourVest Global Private
Equity Limited
|
281
|
167
|
0.4
|
-
|
-
|
Apax Global Alpha
Limited
|
233
|
219
|
0.4
|
-
|
0.1
|
Pantheon International
PLC
|
216
|
138
|
0.3
|
-
|
-
|
Total private equity investment
trusts
|
3,526
|
2,590
|
5.6
|
|
|
Global equity investment
trusts6
|
|
|
|
|
|
Alliance Trust PLC
|
180
|
149
|
0.3
|
-
|
-
|
JPMorgan Global Growth &
Income PLC
|
175
|
150
|
0.3
|
-
|
-
|
Total global equity investment
trusts
|
355
|
299
|
0.6
|
|
|
Real estate investment
trust6
|
|
|
|
|
|
Impact Healthcare REIT
PLC
|
197
|
220
|
0.3
|
0.1
|
0.1
|
Total real estate investment trust
|
197
|
220
|
0.3
|
|
|
Infrastructure investment
trusts6
|
|
|
|
|
|
3i Infrastructure PLC
|
280
|
270
|
0.4
|
-
|
-
|
BBGI Global Infrastructure
SA
|
232
|
260
|
0.4
|
-
|
0.1
|
Pantheon Infrastructure
PLC
|
221
|
251
|
0.4
|
0.1
|
0.2
|
International Public
Partnerships Limited
|
203
|
235
|
0.3
|
-
|
-
|
JLEN Environmental Assets
Group Limited
|
196
|
270
|
0.3
|
-
|
0.1
|
Total infrastructure investment
trusts
|
1,132
|
1,286
|
1.8
|
|
|
Open-ended investment
companies6
|
|
|
|
|
|
Royal London Short Term
Fixed Income Fund (Class Y Income)
|
1,024
|
1,020
|
1.6
|
0.1
|
0.2
|
Royal London Short Term
Money Market Fund (Class Y Income)
|
1,004
|
1,012
|
1.6
|
-
|
-
|
Total open-ended investment
companies
|
2,028
|
2,032
|
3.2
|
|
|
Money-market funds6
|
|
|
|
|
|
Aberdeen Standard Liquidity
Fund (Lux) - Sterling Fund (Class K3)
|
1,000
|
1,000
|
1.6
|
-
|
-
|
Aviva Investors
Sterling Liquidity Fund (Class 3)
|
1,000
|
1,000
|
1.6
|
-
|
-
|
BlackRock
Institutional Sterling Government Liquidity Fund (Core
Dis)
|
1,000
|
1,000
|
1.6
|
-
|
0.1
|
Goldman Sachs Sterling
Government Liquid Reserves Ireland (Institutional)
|
1,000
|
1,000
|
1.6
|
0.4
|
0.4
|
HSBC Sterling
Liquidity Fund (Class A)
|
1,000
|
1,000
|
1.6
|
-
|
-
|
Fidelity Institutional
Liquidity Sterling Fund (Class F)
|
500
|
500
|
0.7
|
-
|
0.2
|
Total money market funds
|
5,500
|
5,500
|
8.7
|
|
|
|
|
|
|
|
|
Total investments
|
57,058
|
51,343
|
90.6
|
|
|
1 Other clients of Maven Capital Partners UK LLP.
2 Retained minority interest following the sale of Quorum Cyber
Security Limited in December 2021.
3 This holding reflects the retained minority interest following
the sale of e.fundamentals (Group) Limited to CommerceIQ in July
2022.
4 Investments are quoted on AIM with the exception of Kanabo
Group PLC, which is listed on the Main Market of the London Stock
Exchange.
5 The holding in this investment resulted from the sale of The
GP Service (UK) Limited, which completed in February 2022. The
unlisted shares in Kanabo GP Limited were, in accordance with the
terms of the original transaction, exchanged for shares in Kanabo
Group PLC, which is listed on the Main Market of the London Stock
Exchange.
6 Treasury management portfolio.
Shaded line indicates that the investment was
completed pre November 2015
Income Statement
For the Six Months Ended 31 May
2024
|
Six months ended to
31 May 2024 (unaudited)
|
Six months ended to
31 May 203 (unaudited)
|
Year ended
30 November 2023 (audited)
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Gain/(loss) on
investments
|
-
|
1,707
|
1,707
|
-
|
(1,560)
|
(1,560)
|
-
|
(1,985)
|
(1,985)
|
Income from investments
|
580
|
-
|
580
|
323
|
-
|
323
|
917
|
-
|
917
|
Other income
|
72
|
-
|
72
|
147
|
-
|
147
|
240
|
-
|
240
|
Investment management
fees
|
(151)
|
(605)
|
(756)
|
(154)
|
(616)
|
(770)
|
(307)
|
(1,228)
|
(1,535)
|
Other expenses
|
(202)
|
-
|
(202)
|
(241)
|
-
|
(241)
|
(452)
|
-
|
(452)
|
Net return on ordinary
activities before taxation
|
299
|
1,102
|
1,401
|
75
|
(2,176)
|
(2,101)
|
398
|
(3,213)
|
(2,815)
|
Tax on ordinary
activities
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Return attributable to Equity
Shareholders
|
299
|
1,102
|
1,401
|
75
|
(2,176)
|
(2,101)
|
398
|
(3,213)
|
(2,815)
|
Earnings per share (pence)
|
0.25
|
0.94
|
1.19
|
0.07
|
(1.99)
|
(1.92)
|
0.36
|
(2.87)
|
(2.51)
|
All gains and losses are recognised in the Income
Statement.
The total column of this statement is the Profit &
Loss Account of the Company. The revenue and capital return columns
are prepared in accordance with the AIC SORP. All items in the
above statement derive from continuing operations. No operations
were acquired or discontinued during the period.
There are no potentially dilutive capital instruments
in issue and, therefore, no diluted earnings per share figures are
relevant. The basic and diluted earnings per share are, therefore,
identical.
The accompanying Notes are an integral part of the
Financial Statements.
Statement of Changes in
Equity
Six Months ended 31 May
2024
Six months ended 31 May 2024
(unaudited)
|
Non-distributable
reserves
|
Distributable
reserves
|
|
Share
capital
£'000
|
Share
premium
account
£'000
|
Capital
redemption
reserve
£'000
|
Capital
reserve
unrealised
£'000
|
Capital
reserve
realised
£'000
|
Special
distributable
reserve
£'000
|
Revenue
reserve
£'000
|
Total
£'000
|
|
At 30 November
2023
|
11,307
|
25,518
|
719
|
5,489
|
998
|
14,134
|
1,172
|
59,337
|
|
Net
return
|
-
|
-
|
-
|
2,093
|
(386)
|
(605)
|
299
|
1,401
|
|
Dividends
paid
|
-
|
-
|
-
|
-
|
-
|
(2,220)
|
(292)
|
(2,512)
|
|
Repurchase
and cancellation of shares
|
(125)
|
-
|
125
|
-
|
-
|
(617)
|
-
|
(617)
|
|
Net
proceeds of share issue
|
1,008
|
4,114
|
-
|
-
|
-
|
-
|
-
|
5,122
|
|
Net
proceeds of DIS issue*
|
53
|
195
|
-
|
-
|
-
|
-
|
-
|
248
|
|
At 31 May
2024
|
12,243
|
29,827
|
844
|
7,582
|
612
|
10,692
|
1,179
|
62,979
|
|
|
|
|
|
|
|
|
|
|
| |
Six months ended 31 May 2023
(unaudited)
|
Non-distributable
reserves
|
Distributable
reserves
|
|
|
Share
capital
£'000
|
Share
premium
account
£'000
|
Capital
redemption
reserve
£'000
|
Capital
reserve
unrealised
£'000
|
Capital
reserve
realised
£'000
|
Special
distributable
reserve
£'000
|
Revenue
reserve
£'000
|
Total
£'000
|
At 30 November
2022
|
10,457
|
19,920
|
346
|
7,422
|
1,050
|
19,974
|
774
|
59,943
|
Net
return
|
-
|
-
|
-
|
(1,545)
|
(15)
|
(616)
|
75
|
(2,101)
|
Dividends
paid
|
-
|
-
|
-
|
-
|
-
|
(2,112)
|
-
|
(2,112)
|
Repurchase
and cancellation of shares
|
(132)
|
-
|
132
|
-
|
-
|
(708)
|
-
|
(708)
|
Net
proceeds of share issue
|
1,024
|
4,801
|
-
|
-
|
-
|
-
|
-
|
5,825
|
Net
proceeds of DIS issue*
|
42
|
193
|
-
|
-
|
-
|
-
|
-
|
235
|
At 31 May
2023
|
11,391
|
24,914
|
478
|
5,877
|
1,035
|
16,538
|
849
|
61,082
|
Year ended 30 November 2023
(audited)
|
Non-distributable
reserves
|
Distributable
reserves
|
|
|
Share
capital
£'000
|
Share
premium
account
£'000
|
Capital
redemption
reserve
£'000
|
Capital
reserve
unrealised
£'000
|
Capital
reserve
realised
£'000
|
Special
distributable
reserve
£'000
|
Revenue
reserve
£'000
|
Total
£'000
|
At 30 November
2022
|
10,457
|
19,920
|
346
|
7,422
|
1,050
|
19,974
|
774
|
59,943
|
Net
return
|
-
|
-
|
-
|
(1,933)
|
(52)
|
(1,228)
|
398
|
(2,815)
|
Dividends
paid
|
-
|
-
|
-
|
-
|
-
|
(2,685)
|
-
|
(2,685)
|
Repurchase
and cancellation of shares
|
(373)
|
-
|
373
|
-
|
-
|
(1,927)
|
-
|
(1,927)
|
Net
proceeds of share issue
|
1,169
|
5,353
|
-
|
-
|
-
|
-
|
-
|
6,522
|
Net
proceeds of DIS issue*
|
54
|
245
|
-
|
-
|
-
|
-
|
-
|
299
|
At 30 November
2023
|
11,307
|
25,518
|
719
|
5,489
|
998
|
14,134
|
1,172
|
59,337
|
*DIS represents the Dividend
Investment Scheme as detailed in the Interim
Review.
The capital reserve unrealised is generally
non-distributable other than the part of the reserve relating to
gains/(losses) attributable to readily realisable quoted
investments which are distributable.
Where all, or an element of the proceeds of sales have
not been received in cash or cash equivalent, and are not readily
convertible to cash, they do not qualify as realised gains for the
purposes of distributable reserves calculations and, therefore, do
not form part of distributable reserves.
The accompanying Notes are an integral part of the
Financial Statements.
Balance Sheet
As at 31 May 2024
|
31 May 2024
(unaudited)
£'000
|
31 May 2023
(unaudited)
£'000
|
30 November 2023
(audited)
£'000
|
Fixed assets
|
|
|
|
Investments at fair value
through profit or loss
|
57,058
|
52,073
|
55,825
|
Current assets
|
|
|
|
Debtors
|
706
|
665
|
660
|
Cash
|
5,505
|
8,528
|
3,117
|
|
6,211
|
9,193
|
3,777
|
Creditors
|
|
|
|
Amounts falling due within
one year
|
(290)
|
(184)
|
(265)
|
Net current assets
|
5,921
|
9,009
|
3,512
|
Net assets
|
62,979
|
61,082
|
59,337
|
Capital and reserves
|
|
|
|
Called up share capital
|
12,243
|
11,391
|
11,307
|
Share premium account
|
29,827
|
24,914
|
25,518
|
Capital redemption
reserve
|
844
|
478
|
719
|
Capital reserve -
unrealised
|
7,582
|
5,877
|
5,489
|
Capital reserve -
realised
|
612
|
1,035
|
998
|
Special distributable
reserve
|
10,692
|
16,538
|
14,134
|
Revenue reserve
|
1,179
|
849
|
1,172
|
Net assets attributable to Ordinary
Shareholders
|
62,979
|
61,082
|
59,337
|
Net asset value per Ordinary Share
(pence)
|
51.44
|
53.62
|
52.48
|
The Financial Statements of
Maven Income and Growth VCT 3 PLC, registered number 04283350, were
approved and authorised for issue by the Board of Directors and
were signed on its behalf by:
Keith Pickering
Chair
18 July 2024
The accompanying Notes are
an integral part of the Financial Statements.
Cash Flow Statement
For the Six Months Ended 31 May
2024
|
Six months ended
31 May 2024
(unaudited)
£'000
|
Six months ended 31 May 2023
(unaudited)
£'000
|
Year ended
30 November 2023
(audited)
£'000
|
Net cash flows from operating
activities
|
(379)
|
(556)
|
(923)
|
Cash flows from investing
activities
|
|
|
|
Purchase of investments
|
(5,708)
|
(13,295)
|
(20,279)
|
Sale of investments
|
6,145
|
896
|
3,742
|
Net cash flows from investing
activities
|
437
|
(12,399)
|
(16,537)
|
Cash flows from financing
activities
|
|
|
|
Equity dividends paid
|
(2,512)
|
(2,112)
|
(2,685)
|
Issue of Ordinary Shares
|
5,459
|
6,042
|
6,928
|
Repurchase of Ordinary
Shares
|
(617)
|
(708)
|
(1,927)
|
Net cash flows from financing
activities
|
2,330
|
3,222
|
2,316
|
|
|
|
|
Net increase/(decrease)
|
2,388
|
(9,733)
|
(15,144)
|
Cash as at beginning of period
|
3,117
|
18,261
|
18,261
|
Cash at end of period
|
5,505
|
8,528
|
3,117
|
The accompanying Notes are
an integral part of the Financial Statements.
Notes to the Financial
Statements
1.
Accounting Policies
The financial information for the six months
ended 31 May 2024 and the six months ended 31 May 2023 comprises
non-statutory accounts within the meaning of s435 of the Companies
Act 2006. The financial information contained in this report has
been prepared on the basis of the accounting policies set out in
the Annual Report and Financial Statements for the year ended 30
November 2023, which have been filed at Companies House and
contained an Auditor's Report that was not qualified and did not
contain a statement under s498(2) or s498(3) of the Companies Act
2006.
2.
Reserves
Share premium
account
The share premium account represents the premium
above nominal value received by the Company on issuing shares net
of issue costs, including £64,703 current period (cumulative
£171,750) trail commission. This reserve is
non-distributable.
Capital
redemption reserve
The nominal value of shares repurchased and
cancelled is represented in the capital redemption reserve. This
reserve is non-distributable.
Capital reserve
- unrealised
Increases and decreases in the fair value of
investments are recognised in the Income Statement and are then
transferred to the capital reserve unrealised account. This reserve
is generally non-distributable other than the part of the reserve
relating to gains/(losses) attributable to readily realisable
quoted investments which are distributable.
Capital reserve
- realised
Gains or losses on investments realised in the
period that have been recognised in the Income Statement are
transferred to the capital reserve realised account on disposal.
Furthermore, any prior unrealised gains or losses on such
investments are transferred from the capital reserve unrealised
account to the capital reserve realised account on disposal. This
reserve is distributable.
Special
distributable reserve
The total cost to the Company of the repurchase
and cancellation of shares is represented in the special
distributable reserve account. The special distributable reserve
also represents capital dividends, capital investment management
fees and the tax effect of capital items. This reserve is
distributable.
Revenue
reserve
The revenue reserve represents accumulated
profits retained by the Company that have not been distributed to
Shareholders as a dividend. This reserve is
distributable.
3.
Return per Ordinary Share
|
Six months ended 31 May 2024
|
The returns per share have been based on the following
figures:
Weighted average number of Ordinary Shares
Revenue return
Capital return
|
117,497,578
£299,000
£1,102,000
|
Total
return
|
£1,401,000
|
Directors'
Responsibility Statement
Each Director believes that, to the best of
their knowledge:
·
the Financial Statements for the six months ended 31 May 2024
have been prepared in accordance with FRS 102, the Financial
Reporting Standard applicable in the UK and the Republic of
Ireland;
·
the Interim Management Report includes a fair review of the
information required by DTR 4.2.7R in relation to the indication of
important events during the first six months, and of the principal
and emerging risks and uncertainties facing the Company during the
second six months, of the year ending 30 November 2024;
and
·
the Interim Management Report includes adequate disclosure of
the information required by DTR 4.2.8R in relation to material
related party transactions and any changes therein.
Other
information
The NAV per Ordinary Share has been calculated
using the number of Ordinary Shares in issue at 31 May 2024, which
was 122,431,944. A Summary of Investment Changes for the six months
under review and an Investment Portfolio Summary as at 31 May 2024
are included above. A full copy of the Interim Report and Financial
Statements will be printed and issued to Shareholders in due
course. Copies of this announcement will be available to the public
at the office of Maven Capital Partners UK LLP, Kintyre House, 205
West George Street, Glasgow, G2 2LW; at the Registered office of
the Company at 6th Floor, Saddlers House, 44 Gutter Lane, London
EC2V 6BR; and on the Company's webpage at: mavencp.com/migvct3.
Neither the content of the Company's webpages
nor the contents of any website accessible from hyperlinks on the
Company's website (or any other website) is incorporated into, or
forms part of, this announcement.
On behalf of
the Board
Maven Capital
Partners UK LLP
Secretary
18 July
2024